Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.248ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.248ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.182ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.182ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.218ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.218ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.12.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.12.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ER.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.640ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
B.1.177.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.251ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.251ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used